| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,348 |
11,834 |
$848K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,687 |
3,207 |
$245K |
| 93923 |
|
343 |
341 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
392 |
339 |
$19K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
56 |
55 |
$13K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
14 |
14 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$4K |
| 99406 |
|
258 |
255 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
25 |
25 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
26 |
26 |
$996.30 |
| 87640 |
|
56 |
55 |
$889.19 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
40 |
39 |
$751.90 |
| 87486 |
|
38 |
38 |
$701.75 |
| 87498 |
|
37 |
37 |
$569.97 |
| 87641 |
|
42 |
41 |
$552.00 |
| 87581 |
|
27 |
25 |
$336.84 |
| 87634 |
|
26 |
26 |
$321.12 |
| 93922 |
|
15 |
15 |
$102.44 |